- Sort by:
- Browse by:
- Free
- slides video
- audio + slides
- All slides included
Invited speaker
Jedd D. Wolchok
Memorial Sloan Kettering Cancer Center, New York, NY, United States
- Permission not
granted for presentation
Invited speaker
Tram K. Lam
National Cancer Institute, Rockville, MD, United States
- Free
- slides video
- audio + slides
- All slides included
Invited speaker
Douglas Hanahan
Swiss Inst. for Exp. Cancer Res. (ISREC), Lausanne, Switzerland
- Free
- audio + slides
- Some slides withheld
Invited speaker
Crystal L. Mackall
Stanford University School of Medicine, Palo Alto, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Invited speaker
Navdeep S. Chandel
Northwestern University, Chicago, IL, United States
- Free
- slides video
- audio + slides
- All slides included
Invited speaker
Michael T. Hemann
MIT Koch Institute for Integrated Cancer Research, Cambridge, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Invited speaker
Elizabeth Maher
UT Southwestern Medical Ctr., Dallas, TX, United States
- Permission not
granted for presentation
Invited speaker
Kojo Elenitoba-Johnson
Univ. of Pennsylvania School of Medicine, Philadelphia, PA, United States
- Free
- audio + slides
- Some slides withheld
Invited speaker
Christopher H. Contag
Stanford Univ. School of Medicine, Stanford, CA, United States
- Permission not
granted for presentation
Invited speaker
Pier Paolo Pandolfi
BIDMC Cancer Center/Harvard Medical School, Boston, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Invited speaker
Ricky W. Johnstone
Peter MacCallum Cancer Ctr., Melbourne, Australia
- Permission not
granted for presentation
Tracking cancer evolution through therapy (TRACERx): Implications for immune targeting and surveillance
Charles Swanton
The Francis Crick Institute and UCL Cancer Institute, London, United Kingdom
- Free
- podium video
- slides video
- audio + slides
- All slides included
The AML genome(s)
Timothy J. Ley
Section of Stem Cell Biology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States
- Free
- podium video
- audio + slides
- Some slides withheld
Dissecting the complex ecosystem of malignant tumors with single cell RNA-Seq
Aviv Regev
Massachusetts Institute of Technology, Cambridge, MA, United States
- Permission not
granted for presentation
The evolution of cancer in response to targeted therapies
Jeffrey A. Engelman
Massachusetts General Hospital, Boston, MA, United States
- Free
- audio + slides
- Some slides withheld
Modulating the p53-p21 axis to protect normal tissue from radiation injury
David G. Kirsch
Duke University Medical Center, Durham, NC, United States
- Free
- slides video
- audio + slides
- All slides included
Genetic or pharmacological clearance of senescent cells rejuvenates irradiated hematopoietic stem cells
Daohong Zhou
University of Arkansas for Medical Sciences, Little Rock, AR, United States
- Free
- audio + slides
- Some slides withheld
Using FDG-PET and targeting the AKT/PI3K pathway to improve outcome of cervical cancer treated with radiochemotherapy
Julie K. Schwarz
Washington University School of Medicine, St. Louis, MO, United States
- Permission not
granted for presentation
Immune checkpoint blockade and radiation activate non-redundant immune mechanisms in cancer
Andy J Minn
Abramson Family Cancer Research Inst., Philadelphia, PA, United States
- Free
- slides video
- audio + slides
- All slides included
Current clinical and translational dilemmas in breast cancer
Nancy E. Davidson
University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States
- Permission not
granted for presentation
Genomic stratification of breast cancer and its implications
Carlos M. Caldas
Cancer Research UK Cambridge Research Inst., Cambridge, United Kingdom
- Permission not
granted for presentation
Advances and challenges in expanding the armamentarium of drugs for breast cancer
Lori S Friedman
Genentech, Inc., South San Francisco, CA, United States
- Free
- Unknown permission
for presentation
Chairperson
Stanley Riddell
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- Free
- audio + slides
- Some slides withheld
Novel designs and targets for CAR T cells
Stanley Riddell
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- Free
- slides video
- audio + slides
- All slides included
Fueling CAR T cells with regular or premium gas
Carl H. June
Abramson Cancer Center of University of Pennsylvania, Philadelphia, PA, United States